InMedica: Slovenian Device Incubator Looks To Fill Infrastructure Gap
Executive Summary
One of the major challenges faced by a European medtech start-up community that is already arguably undersized has been a lack of infrastructure. A group of medical device executives are trying to address that problem through the launch of an incubator, InMedica, built upon a network of support services that is integrally connected to the incubator, in effect forming its own medical device cluster in the unlikely setting of Slovenia, a country of two million people in south central Europe.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.